Table 1.
SAE-1 expression correlated with clinicopathologic parameters in CRC.
| Number of Patients | SAE-1 Expression (n, %) | p-Value | ||
|---|---|---|---|---|
| Low | High | |||
| Sex | 0.414 | |||
| Male | 100 | 61 (37.9%) | 39 (24.2%) | |
| Female | 61 | 33 (20.5%) | 28 (17.4%) | |
| Age | 0.187 | |||
| ≥60 | 37 | 18 (11.2%) | 19 (11.8%) | |
| <60 | 124 | 76 (47.2%) | 48 (29.8%) | |
| Tumor size | 0.191 | |||
| ≥5 cm | 60 | 31 (19.3%) | 29 (18.0%) | |
| <5 cm | 101 | 63 (39.1%) | 17 (12.3%) | |
| T stage | 1 | |||
| T1 + T2 | 56 | 33 (20.5%) | 23 (14.3%) | |
| T3 + T4 | 105 | 61 (37.9%) | 44 (27.3%) | |
| N stage | 0.053 | |||
| N0 | 94 | 61 (37.9%) | 33 (20.5%) | |
| N1 + 2 | 67 | 33 (20.5%) | 34 (21.1%) | |
| M stage | 0.006 | |||
| M0 | 120 | 78 (48.4%) | 42 (26.1%) | |
| M1 | 41 | 16 (9.9%) | 25 (15.5%) | |
| Pathologic stage | 0.081 | |||
| I + II | 83 | 54 (33.5%) | 29 (18%) | |
| III + VI | 78 | 40 (24.8%) | 38 (23.6%) | |
| Recurrent | 0.327 | |||
| Yes | 60 | 32 (19.9%) | 28 (17.4%) | |
| No | 101 | 62 (38.5%) | 39 (24.2%) | |
| Vascular invasion | 0.268 | |||
| Yes | 78 | 42 (26.1%) | 26 (22.4%) | |
| No | 83 | 52 (32.3%) | 31 (19.3%) | |
| Perineural invasion | 0.423 | |||
| Yes | 31 | 16 (9.9%) | 15 (9.3%) | |
| No | 130 | 78 (48.4%) | 52 (32.3%) | |